ArticleClinical ophthalmology (Auckland, N.Z.)2026
Glucagon-Like Peptide-1 Analogs Associated with a Reduced Risk of Legal Blindness in Type 2 Diabetics with Cardiovascular Risks.
Ethan Jarrett et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.